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Mladen J. Kocica, MD,a Mile R. Vranes, PhD,a Dusan Kostic, PhD,a
Natasa Kovacevic-Kostic, MD,a Vesna Lackovic, PhD,b Vesna Bozic-Mihajlovic, MD,c
Milos M. Velinovic, PhD,a Aleksandar Dj. Mikic, MD,a and
Nevena Dimitrijevic-Kalezic, PhD,d Serbia and MontenegroIntracardiac leiomyomatosis (ICL) is a rare and dangerousform of intravenous leiomyomatosis (IVL).1-5 The case ofICL presented here depicts some diagnostic and surgicaldifficulties that may arise from the rarity and complexity of
this condition. Further, to our best knowledge, neither the mass nor
the growth rate of the abdominal part of the presented ICL has
been described in the available literature. Finally, this case and
extensive literature search allowed us to clarify some important
questions pertaining to this entity.
Clinical Summary
A 36-year-old white woman (multigravid, biparous), who under-
went a right salpingo-oophorectomy 7 years before admission,
presented with a recurrent growing pelvic mass, dyspnea, fatigue,
weight loss, ascites, leg swelling, and dysmenorrhea.
Abdominal and pelvic ultrasound revealed a right-sided, uterine
adnexal tumor (5  11 cm) penetrating the inferior vena cava
(IVC) (Figure 1, a). After a clinical episode of severe dyspnea,
tachycardia, and syncope, echocardiography revealed the presence
of a mass in the right atrium, originating from the IVC and
protruding across the tricuspid valve throughout the cardiac cycle.
The patient was transferred for “palliative” cardiac surgery with a
presumptive diagnosis of recurrent ovarian malignancy with intra-
cardiac extension.
Repeat abdominal ultrasound revealed tumor-free left iliac and
femoral veins, so this route was used, in addition to the superior
vena cava, for optimal venous drainage during cardiopulmonary
bypass (CPB). On beating heart right atriotomy, a solid, molding
tumor (250 g, 20  4 cm) was easily removed from the right heart
chambers by slight traction. A conically shaped IVC portion was
sharply excised at an accessible and safe distance. Weaning from
CPB and the rest of procedure were uneventful.
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chemical analyses (Figure 1, b-d)
indicated IVL. Histologic diag-
nosis was confirmed using inter-
national teleconsultation facili-
ties (Department of Pathology,
Thoraxklinik, Heidelberg, Germany).
Figure 1. a, Abdominal ultrasound revealing presence of tumor in
IVC (arrow). Doppler signals indicated incomplete caval obstruc-
tion. b, ICL: hematoxylin-eosin 16  10; c, ICL: myoglobin , 25 
10; d, ICL: desmin , 25  10; e, IVL: giant tumor mass (8.5 kg, 45
Dr Kocica 20  20 cm) excised at abdomin
ember 2005al stage operation.
Brief CommunicationsTABLE 1. Intracardiac leiomyomatosis: Review of the literature
Cases reported after 2003
No. Reference C/A ICL Surgery
1 Kocica et al. 2005 (current report) 1/36 RV Two-stage
2 Ozer et al. Echocardiography. 2005;22:514-16 1/43 RA Two-stage
3 Thukkani et al. Ann Thorac Surg. 2005;79:707-9 1/36 RV Two-stage
4 Moorjani et al. J Card Surg. 2005;20:382-5 1/64 RV One-stage
5 Murphy et al. EJVES Extra. 2005;9:4-6 1/49 RA One-stage
6 Bennett et al. Nat Clin Pract Cardiovasc. Med 2005;2:369-72 1/58 RV One-stage
7 DeRubertis et al. J Vasc Surg. 2004;40:554-8 1/45 RA Two-stage, EVS
8 Topcuoglu et al.Ann Thorac Surg. 2004;78:330-2 1/58 RV Two-stage
9 Uchida et al. Obstet Gynecol. 2004;103:1068-70 1/53 RV One-stage
10 Feng et al. Chin Med Sci J. 2004;19:55. 1/38 RA Two-stage
11 Nishizawa et al. J Am Coll Surg. 2004;198:842-3 1/51 RA One-stage, VATS, CPB
12 Sakamoto et al. Jpn J Thorac Cardiovasc Surg. 2004;52:148-51 1/72 RV One-stage
13 Jerez-Anera et al. Rev Esp Anestesiol Reanim. 2004;51:40-3 1/61 RA One-stage
14 Sasaki et al. Nippon Naika Gakkai Zasshi. 2004;93:142-4 1/72 RA One-stage
15 Lam et al. J Vasc Surg. 2004;39:465-9 2/41,47 RA Two-stage
16 Saitoh et al. Gynecol Obstet Invest. 2004;58:168-70 1/NA RA One-stage
17 Burke et al. Pathology. 2004;36:202-3 1/47 PA Death before surgery
Total number of cases 18/51 (36-72) RA  10 None 1 (4.4%)
RV  7 One-stage 9 (27.9%)
PA  1 Two-stage 8 (42.7%)
Cases reported before 2003*
No. Reference C/A (m) ICL Surgery
1 Lam et al.4 Review of cases with intracardiac extension between
1900 and 2003
68/47 (26-76) RA  31 None 3 (4.4%)
RV  31 Incomplete excision 17 (25.0%)
PA  6 One-stage 19 (27.9%)
Two-stage 29 (42.7%)
2 Nam et al.3 Review of cases with intracardiac extension between
1975 and 2002
16/50 (26-72) RA  7 Incomplete excision 2 (12.5%)
RV  9 One-stage 5 (33.3%)
Two-stage 9 (56.2%)
3 Harris and Karakousis2 Review of cases with intracardiac extension
between 1975 and 1999
34/48 (26-72) RA  12 Incomplete excision 6 (17.6%)
RV  22 One-stage 9 (26.5%)
Two-stage 15 (44.1%)
NA 4 (11.8%)
4 Iverson et al.1Review of cases with intracardiac extension up to 1983 6/NA NA Incomplete excision 2 (33.3%)
Two-stage 1 (16.7%)
NA 3 (50.0%)
Total number of cases* 95/48 (26-76) RA  35 None 3 (3.1%)
RV  48 Incomplete excision 20 (21.1%)
PA  6 One-stage 24 (25.3%)
NA  6 Two-stage 41 (43.1%)
NA 7 (7.4%)
Cumulative data*
Total number of cases up to 2005* 113/49.5 (26-76) RA  45 None 4 (3.5%)
RV  55 Incomplete excision 20 (17.7%)
PA  7 One-stage 33 (29.2%)
NA  6 Two-stage 49 (43.4%)
NA 7 (6.2%)
ICL, Intracardiac leiomyomatosis; C/A, cases/age; (m), mean age (age range in parentheses); RA, right atrium; RV, right ventricle; PA, pulmonary artery; EVS,
endovascular surgery; VATS, video-assisted thoracoscopic surgery; CPB, cardiopulmonary bypass; NA, not available. *Identical reports from References
1, 2, 3, and 4 were counted as 1 in total score.
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Brief CommunicationsA second-stage operation was scheduled to remove abdominal
and intracaval tumor remnants. During 1 month, between 2 oper-
ations, the abdominal mass doubled in size, resembling terminal
gravidity, without any other clinical worsening in the patient’s
condition except increased leg swelling.
On median laparotomy, the right colon and small bowel were
mobilized and Kocherization of duodenum was performed to gain
safe access to the IVC. Vessel loops were placed around the IVC
below the renal veins and inferiorly, below the orifice of the right
ovarian vein. After blunt mobilization of the retroperitoneal mass,
elliptical excision of the IVC around the right ovarian vein orifice
allowed traction delivery of the intracaval portion of the tumor. The
IVC was closed with linear suture. The entire tumor (8.5 kg, 45 20
 20 cm) and the uterus were removed en bloc (Figure 1, d).
The patient’s postoperative course was complicated with ex-
cessive bleeding, and relaparotomy was necessary. Hemostatic
sutures were placed on the uterine cervical stump, and control of
the bleeding site was fully accomplished.
The rest of the postoperative course was uneventful. Control
abdominal ultrasonography and echocardiography revealed no vis-
ible intravascular tumor remnants. Nine months after the patient’s
discharge, no recidivant or metastatic masses were detected by
ultrasonography.
Discussion
Since the first description of ICL by Durck and Hormann in 1907,
113 cases have been published.2,3 Before 1980, when Timmis and
colleagues extracted an ICL,2 all attempts to do so were fatal. A new
era in treatment of IVL and ICL began in 1982, when Ariza and
colleagues performed the first successful 2-stage total resection.2
We performed a comprehensive literature search, including all
available electronic and paper sources, together with the references
in each publication, to identify all reported cases of ICL. A
compendium of information from isolated reports is summarized
in Table 1. We believe that ICL is not so rare an entity as
previously thought (during the past 2 years, 16% of all ICL cases
were reported). A higher index of clinical suspicion with the
availability of contempory imaging tools (ie, abdominal and car-
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aging, and venography) will lead to an increased number of reports
in the future.2-5
IVL and ICL are benign (estrogen sensitive?) intravascular
proliferations of smooth muscle cells arising from the uterine vein
wall or the myometrium (ie, uterine leiomyoma). The tumor has
the potential to grow inside the veins of broad ligament, extending
to the IVC through different routes (ie, iliac veins and ovarian
veins), reaching up to the right heart chambers and occasionally
the pulmonary artery.1-5
Because a complete removal of the tumor is mandatory,1-5 an
adequate preoperative diagnosis should provide detailed informa-
tion about the tumor localization, extravascular and intravascular
diameters, site of vascular entry, and patency of iliac and femoral
veins.5
The optimum and safest strategy is a single or 2-stage proce-
dure with an abdominal approach and subsequent thoracic ap-
proach. The abdominal stage should ensure complete extravascular
tumor excision and control of the vascular entry site(s). The
thoracic stage, preferably with short total CPB on the beating
heart, should allow easy tumor withdrawal from the right cardiac
chambers and IVC.1-5
References
1. Iverson LIG, Lee J, Drew D, Sharp J, Ecker RR, Young JN, et al.
Intravenous leiomyomatosis with cardiac extension. Tex Heart Inst J.
1983;10:275-8.
2. Harris LM, Karakousis CP. Intravenous leiomyomatosis with cardiac
extension: tumor thrombectomy through an abdominal approach. J Vasc
Surg. 2000;31:1046-51.
3. Nam MS, Jeon MJ, Kim YE, Kim JW, Park KH, Hong YS. Pelvic
leiomyomatosis with intracaval and intracardiac extension: a case report
and review of the literature. Gynecol Oncol. 2003;89:175-80.
4. Lam PM, Lo KWK, Yu MY, Wong WS, Lau JYW, Arifi AA, et al.
Intravenous leiomyomatosis with atypical histologic features: a case
report. Int J Gynecol Cancer. 2003;13:83-7.
5. Roques F, Sanchez B, Bucher B, Lariviere J. Role of pre-operative
assessment in the surgical management of leiomyoma extended to the
right heart chambers: a compendium of information from isolated
reports. Eur J Cardiothorac Surg. 2001;19:522-4.
ember 2005
